# EDGAR Filing Document

**Accession Number:** 0001840416
**File Stem:** 0001171843-25-005696
**Filing Date:** 2025-9
**Character Count:** 15330
**Document Hash:** 00e016d3b5e40a684bb29c23071a6a80
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001171843-25-005696.hdr.sgml**: 20250903

**ACCESSION NUMBER**: 0001171843-25-005696

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20250903

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250903

**DATE AS OF CHANGE**: 20250903

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Sono Group N.V.
- **CENTRAL INDEX KEY:** 0001840416
- **STANDARD INDUSTRIAL CLASSIFICATION:** SEMICONDUCTORS & RELATED DEVICES [3674]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 000000000
- **STATE OF INCORPORATION:** P7
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41066
- **FILM NUMBER:** 251287713

**BUSINESS ADDRESS:**
- **STREET 1:** WALDMEISTERSTRASSE 93
- **CITY:** MUNICH
- **STATE:** 2M
- **ZIP:** 80935
- **BUSINESS PHONE:** 49-89-45205818

**MAIL ADDRESS:**
- **STREET 1:** WALDMEISTERSTRASSE 93
- **CITY:** MUNICH
- **STATE:** 2M
- **ZIP:** 80935

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**__________________________**

**FORM 8-K**

**__________________________**

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(D)**

**OF THE SECURITIES EXCHANGE ACT OF 1934**

**Date of Report (Date of earliest event reported): September 3, 2025**

**__________________________**

**Sono Group N.V.** **(Exact name of registrant as specified in its charter)**

**__________________________**

---

| | | |
|:---|:---|:---|
| **The Netherlands**<br>| **001-41066** | **98-1828632**<br>|
| (State or other jurisdiction<br> of incorporation) | (Commission File Number) | (IRS Employer<br> Identification No.) |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Waldmeisterstrasse 93, Munich, Germany**<br>| &nbsp;&nbsp;**80935**<br>|
| (Address of principal executive offices) | (Zip Code) |

---

**+49 (0)89 4520 5818**

(Registrant's telephone number, including area code)

**__________________________**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Not Applicable | Not Applicable | Not Applicable |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

---

| | |
|:---|:---|
| **Item 8.01** | **Other Items.** |

---

On September 3, 2025, Sono Group N.V. (the "Company") furnished an unaudited pro forma condensed consolidated balance sheet and statement of income as of and for the six months ended June 30, 2025 (the "Pro Forma Financial Information") as part of the Company's application for listing on the Nasdaq Capital Market ("Nasdaq").

The Pro Forma Financial Information gives effect to the transactions contemplated by the following previously-disclosed agreements: (i) the securities purchase agreement (the "Securities Purchase Agreement") entered into between the Company and YA II PN, Ltd. ("Yorkville") on December 30, 2024, pursuant to which Yorkville committed to provide limited financing to the Company in the amount of $5,000,000 (the "Yorkville Commitment") in the form of a new convertible debenture (the "Commitment Debenture"), subject to certain conditions and limitations, including the Company's receipt of notice from Nasdaq that the Company has met all the applicable requirements for listing of the Company's ordinary shares on Nasdaq, (ii) the exchange agreement (the "Exchange Agreement") entered into between the Company and Yorkville on December 30, 2024, pursuant to which the Company agreed, subject to the satisfactions of certain conditions precedent, to issue 1,242 shares of preferred stock of the Company, each with a nominal value of €300 (the "Preferred Shares"), to Yorkville solely in exchange for the surrender and cancellation of all of the debentures held by Yorkville, including the Commitment Debenture, if issued, and the Advance Debentures (as defined below), (iii) the omnibus amendment to transaction documents entered into between the Company and Yorkville on February 12, 2025 (the "First Omnibus Amendment"), which provided for, among other things, an immediate advance of $1,000,000 of the Yorkville Commitment in the form of a $1,000,000 secured convertible debenture (the "First Advance Debenture"), (iv) the omnibus amendment to transaction documents entered into between the Company and Yorkville on March 7, 2025 (the "Second Omnibus Amendment"), which, among other things, modified the terms of the Exchange Agreement to amend the floor price provided for in the Exchange Agreement, (v) the omnibus amendment to transaction documents entered into between the Company and Yorkville on March 25, 2025 (the "Third Omnibus Amendment"), which provided for, among other things, a second immediate advance of $1,000,000 of the Yorkville Commitment in the form of a $1,000,000 secured convertible debenture (the "Second Advance Debenture") and (vi) the omnibus amendment to transaction documents entered into between the Company and Yorkville on April 24, 2025 (the "Fourth Omnibus Amendment"), which provided for, among other things, a third immediate advance of $500,000 of the Yorkville Commitment in the form of a $500,000 secured convertible debenture (the "Third Advance Debenture"), (vii) the omnibus amendment to transaction documents entered into between the Company and Yorkville on May 26, 2025 (the "Fifth Omnibus Amendment" and together with the First Omnibus Amendment, the Second Omnibus Amendment, the Third Omnibus Amendment, and the Fourth Omnibus Amendment, the "Omnibus Amendments"), which provided for, among other things, a fourth immediate advance of $750,000 of the Yorkville Commitment in the form of a $750,000 secured convertible debenture (the "Fourth Advance Debenture" and together with the First Advance Debenture, the Second Advance Debenture and the Third Advance Debenture, the "Advance Debentures").

As a final adjustment to net equity, Yorkville will add an additional $2,200,000 (€1,850,000) of secured convertible debenture subject to Nasdaq approving the Company's requested uplisting to Nasdaq Capital Markets.

Additional information and background on the Securities Purchase Agreement, the Exchange Agreement, the Omnibus Amendments and the other agreements and transactions related thereto may be found in the Company's Form 6-K filed with the Securities and Exchange Commission ("SEC") on December 30, 2024 and the Company's Form 8-Ks filed with the SEC on February 13, 2025, March 7, 2025, March 26, 2025, April 25, 2025 and May 26, 2025. The Company's listing application has not yet been approved by Nasdaq, and there is no assurance that its listing application will be approved by Nasdaq.

---

| | |
|:---|:---|
| **Item 9.01** | **Financial Statements and Exhibits.** |

---

(d) Exhibits.

---

| | |
|:---|:---|
| <u>Exhibit No.</u> | <u>Description of Exhibit</u> |
| [99.1](exh_991.htm) | [Sono Group N.V. pro forma condensed consolidated balance sheet and statement of income as of and for the six months ended June 30, 2025](exh_991.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **Sono Group N.V.** | **Sono Group N.V.** |
| Dated: September 3, 2025 | By: | /s/ George O'Leary |
|  |  | Name: George O'Leary |
|  |  | Title: Managing Director |

---

## Exhibit 99.1

**Exhibit 99.1**

![](logo.jpg)

**Sono Group N.V. pro forma condensed consolidated Balance Sheet**

**and Statement of Income as of and for the six months ended**

**June 30, 2025**

**TABLE OF CONTENTS**

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;Proforma Condensed Consolidated Statements of Income (Loss) | 3 |
| &nbsp;&nbsp;&nbsp;Proforma Preliminary Condensed Consolidated Balance Sheets | 4 |
| &nbsp;&nbsp;&nbsp;A. New Issuance of $7.2 Million Debenture Adjustment | 5 |
| &nbsp;&nbsp;&nbsp;B. Conversion of all existing debt to preferred equity | 5 |
| &nbsp;&nbsp;&nbsp;C. Changes to the fair value in Convertible Notes Payable | 5 |
| &nbsp;&nbsp;&nbsp;D. Change in Subscribed Capital | 5 |
| &nbsp;&nbsp;&nbsp;E. Net Equity Converted to US Dollars | 6 |

---

#### Proforma Condensed Consolidated Statements of Income (Loss)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | **Pro Forma Adjustments** | **Pro Forma Adjustments** | |
|  | <br>**Six months <br> ended June 30, <br> 2025<br> (unaudited)<br>** <br>** <br>kEUR | **mUSD 5 New<br> Convertible<br> Debenture<br> (A)**<br>kEUR | **Debt to Equity<br> Conversion<br> Adjustments<br> (B)**<br>kEUR | <br>**Pro Forma<br> Combined<br> Following<br> Recapitalization**<br>kEUR |
| Revenue | 51 |  |  | 51 |
| Cost of goods sold | 39 | - | - | 39 |
| Gross profit | 12 | - | - | 12 |
| Cost of development expenses | (968) |  |  | (968) |
| Selling and distribution expenses | (474) |  |  | (474) |
| General and administrative expenses | (2281) |  |  | (2281) |
| Gain/(loss) on deconsolidation/reconsolidation |  |  |  |  |
| Other operating income / (exp) | 132 |  |  | 132 |
| Operating Income/(Loss) | (3579) | - | - | (3579) |
| Income/(expense) from changes in fair value of convertible debt carried at Fair value | 11144 |  |  | 11144 |
| Gain of foreign currency translation | 460 | - | - | 460 |
| Income/(Loss) before tax | 8025 | - | - | 8025 |
| Taxes on income |  |  |  |  |
| Deferred taxes on expense | - | - | - | - |
| Income/(Loss) for the period | 8025 | - | - | 8025 |

---

#### Proforma Preliminary Condensed Consolidated Balance Sheets

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | **Pro Forma Adjustments** | **Pro Forma Adjustments** | **Pro Forma<br> Combined<br> following<br> Recapitalization**  |
| |<br>**June 30, <br> 2025<br> Unaudited<br>** <br>kEUR | **mUSD 5 New<br> Convertible<br> Debenture/Other <br> (A)**<br>kEUR | **Debt to Equity<br> Conversion<br> Adjustments**<br>**(B)**<br>** <br>kEUR | <br>kEUR |
| ASSETS |  |  |  |  |
| Noncurrent assets |  |  |  |  |
| Property, plant and equipment | 121 |  |  | 121 |
| Right-of-use assets | 602 |  |  | 602 |
| Other financial assets | 536 | - | - | 536 |
|  | 1259 | - | - | 1259 |
| Current assets |  |  |  |  |
| Inventory | 298 |  |  | 298 |
| Other financial assets | 100 |  |  | 100 |
| Other non-financial assets |  |  |  |  |
| Cash | 339 | 1,580<sup>(A)</sup>+1,850<sup>(A)</sup> | - | 3769 |
|  | 737 | 3430 | - | 4167 |
| Total assets | 1996 | 3430 | - | 5426 |
| EQUITY AND LIABILITIES |  |  |  |  |
| Equity |  |  |  |  |
| Subscribed capital (ordinary & high voting) | 48 <sup>(D)</sup> |  |  | 48 |
| Capital and other reserves | 298699 | 85 <sup>(A)</sup> | 39657 <sup>(B)</sup> | 338441 |
| Accumulated deficit | (313403) | (20971) <sup>(C)</sup> | - | (334374) |
| Total Equity | (14656) | (20886) | 39657 | 4115 <sup>(E)</sup> |
| Current Liabilities |  |  |  |  |
| Lease Liability (Current 167k LT 435k) | 602 |  |  | 602 |
| Taxes payable | - | - | - | - |
| Subtotal | 602 | - | - | 602 |
| Financial liabilities | 15341 | &nbsp;&nbsp;&nbsp;&nbsp;20,971<sup>(C)</sup>+1,495+ 1,850<sup>(A)</sup> | (39657) <sup>(B)</sup> |  |
| Trade and other payables | 697 |  |  | 697 |
| Other liabilities | 12 | - | - | 12 |
|  | 16050 | 24316 | (39657) | 709 |
| Total equity and liabilities | 1996 | 3430 | - | 5426 |

---

&nbsp;&nbsp;&nbsp;&nbsp;A. New Issuance of $7.2 Million Debenture Adjustment

As part of its strategic financial restructuring, Sono Group N.V. has entered into a Securities Purchase Agreement with Yorkville to issue a new secured convertible debenture with a principal amount of $5.0 million, subject to Nasdaq approving the Company's requested uplisting to Nasdaq Capital Markets. Yorkville had advanced $3.25 million (2.7M Euros) of the $5.0 million as of 6/30/25, with $1.75 million (1.495M Euros) still subject to Nasdaq Approval. The cash section reflects 1.495M Euros left as the company has received $3.25M as advances through Q2 2025, which is already reflected in the 6/30/25 balance sheet, plus 85K Euros from private equity sales completed in August for a total cash increase of 1.58M Euros. As a final adjustment to net equity, Yorkville will add an additional $2.2M (1.85M Euros) of secured convertible debenture subject to Nasdaq approving the Company's requested uplisting to Nasdaq Capital Markets.

&nbsp;&nbsp;&nbsp;&nbsp;B. Conversion of all existing debt to preferred equity

Sono Group N.V. signed an Exchange Agreement with Yorkville to convert the newly issued debenture, along with all other existing outstanding convertible debentures, into preferred equity. The total debt being exchanged amounts to approximately €39.66 million, including the €32.7 million of previously issued convertible debentures and the $7.2 million new debentures. Under the agreement, this notes payable will be converted into 1,242 newly issued preferred shares, plus an additional 73 preferred shares for a total of 1,315 preferred shares each with a nominal value of €300. These shares are convertible into 30,000 ordinary shares post-implementation of the reverse stock split.

&nbsp;&nbsp;&nbsp;&nbsp;C. Changes to the fair value in Convertible Notes Payable

The income from changes in fair value of convertible notes payable carried at Fair value of 20.97M Euros is reversed as part of the exchange agreement when the actual value of the total convertible notes payable plus accrued interest is all converted to preferred equity.

&nbsp;&nbsp;&nbsp;&nbsp;D. Change in Subscribed Capital

Change in subscribed capital is due to reverse split of 75 to 1 along with change in nominal value of ordinary and high voting shares.

&nbsp;&nbsp;&nbsp;&nbsp;E. Net Equity Converted to US Dollars

Net Equity of 4.115M Euros is converted to $4.815M at an exchange rate as of 6/30/25 of 1.17 from Euros to US dollars, exceeding the needed $4M required minimum net equity.